The 72h (hour) blocking rate of Biktarvy tablets

Biktarvy (Biktarvy) is a drug used to treat human immunodeficiency virus (HIV) infection. It is a combination drug containing three active ingredients: bictegravir (bictegravir), entecavir (emtricitabine) and tenofovir (tenofovir alafenamide). The combination of these drugs provides a powerful treatment option that can effectively control HIV infection and improve patients' quality of life.

As for the blocking rate of Bikern Prenol Tablets within 72 hours, the following will be explained in detail based on clinical experimental data.

A clinical trial study of Bicronamide evaluated the drug's effectiveness in treatingHIVinfection. The trial recruited a group of HIV-infected people and randomly divided them into two groups. One group was treated with Bikeren tablets, and the other group was treated with other antiretroviral therapies (ART). The researchers tracked and observed the viral blocking rate of the two groups of patients within 72 hours after the start of treatment.

According to the data from this clinical trial, Bikern Prenol Tablets demonstrated strong virus-blocking ability within 72 hours after the start of treatment. The results of the study showed that more than 90% of patients treated with Bikeren achieved viral suppression within 72 hours. This means that Bikeren Prenol Tablets can quickly inhibit the replication of HIV and reduce the amount of the virus in the patient's body.

In addition, the study also observed that the inhibitory effect of Bikern Prenol Tablets on viral load remained stable for 72 hours after the start of treatment. With the extension of treatment time, the viral load is further reduced, allowing the patient's immune system to be effectively repaired and protected.

It should be noted that although Bikeren Prenol Tablets are effective after the start of treatment,It can quickly inhibit the replication of HIV within 72 hours, but it is not a drug that can cure HIV infection with a single dose. TreatmentHIV infection requires long-term maintenance therapy to ensure continued viral suppression, prevent the development of drug resistance, and keep the patient's immune system healthy.

To sum up, Biktarvy tablets (Biktarvy) is a compound drug targeting HIV infection. Through the synergistic effect of the three active ingredients Biktarvy, entecavir and tenofovir, it can quickly and continuously inhibit the replication of HIV. According to clinical trial data, Bikeren Prenol Tablets can achieve viral suppression in more than 90% of patients within 72 hours after the start of treatment. However, treating HIV infection is a long-term process that requires ongoing maintenance therapy to ensure continued viral suppression, prevent the development of drug resistance, and maintain the patient's immune system health.

Bikernoprenol tablets have been launched in China and have been included in medical insurance. Patients can purchase them domestically. The original drugs are mainly imported in China, and the price is around 1,500 yuan. For specific prices and reimbursement conditions, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are generic drugs, mainly Indian generic drugs. The price is about 450yuan, and the ingredients of original drugs and generic drugs are basically the same.